DNAJA2 Antibody

What is DNAJA2 and what is its primary cellular function?

DNAJA2 (DnaJ Heat Shock Protein Family Member A2) is a member of the heat shock protein 40 (HSP40) family that serves as a co-chaperone for Hsp70/Hsc70 chaperones. It plays a crucial role in protein folding and cellular stress response mechanisms by assisting in proper protein folding and preventing misfolding under stressful conditions . The protein is approximately 46 kDa and is involved in multiple cellular processes beyond stress response, including transcription-coupled repair and viral response pathways .

Methodologically, when studying DNAJA2 function, researchers should consider:

• Using both gain-of-function (overexpression) and loss-of-function (knockdown/knockout) approaches

• Implementing stress induction protocols to observe DNAJA2 regulation

• Employing co-immunoprecipitation to identify DNAJA2 interaction partners

What is the domain structure of DNAJA2 and how does it relate to function?

DNAJA2 contains several functional domains that contribute to its chaperone activity:

The internal structure between zinc finger motifs (m2 subdomain) is particularly important, as deletion of this region (DJA2-Δm2) abolishes the protein's ability to release substrates while maintaining substrate binding capability . This domain organization allows DNAJA2 to coordinate binding and release of substrates in conjunction with the Hsc70 ATPase cycle.

How should I select the appropriate DNAJA2 antibody for my specific experimental application?

Selection of DNAJA2 antibodies should be guided by the intended application and experimental design:

When selecting an antibody, consider:

• The specific epitope recognized (N-terminal, central region, or C-terminal)

• Species cross-reactivity if working with non-human models

• Validation data in your specific cell type or tissue

• Whether the antibody has been validated for your specific application

What validation methods should I employ to ensure the specificity of my DNAJA2 antibody?

Comprehensive validation of DNAJA2 antibodies requires multiple approaches:

• Western blot validation:

  • Include positive control lysates (A431, A375, or brain tissue samples shown to express DNAJA2)

  • Compare with recombinant DNAJA2 protein as size reference

  • Perform knockdown/knockout validation to confirm specificity

  • Check for cross-reactivity with closely related family members (DNAJA1)

• Immunofluorescence validation:

  • Compare staining patterns with published subcellular localization data

  • Perform co-localization studies with known interaction partners

  • Include DNAJA2 knockout cells as negative controls

  • Validate signal specificity using peptide competition assays

• Functional validation:

  • Confirm antibody interference with known DNAJA2 functions

  • Test antibody recognition of both native and denatured forms as needed

How does DNAJA2 interact with viral proteins and what methodologies best characterize these interactions?

DNAJA2 has been identified as an important host factor in viral infection, particularly with Japanese encephalitis virus (JEV). Research has demonstrated that:

• DNAJA2 interacts directly with JEV NS3 and NS5 proteins to form part of the viral replication complex

• Overexpression of DNAJA2 promotes JEV infection, while knockdown suppresses viral propagation

• The C-terminal domain of DNAJA2 is critical for interaction with viral NS3

Methodological approaches to study DNAJA2-viral protein interactions:

• Co-immunoprecipitation (Co-IP) coupled with mass spectrometry to identify interaction partners

• Truncation mutants to map interaction domains (particularly the C-terminal domain)

• Indirect immunofluorescence assays to visualize co-localization with viral components

• Viral titer assays following DNAJA2 manipulation to assess functional significance

• Ubiquitin-proteasome pathway inhibitors (e.g., MG132) to assess effects on viral protein stability

Research has shown that DNAJA2 knockdown results in NS3 protein degradation, which can be restored by MG132 treatment, suggesting DNAJA2 stabilizes viral proteins by preventing proteasomal degradation .

What is the mechanistic basis for DNAJA2's role in substrate release during protein folding?

DNAJA2's mechanism of substrate release is essential for its chaperone function and differs from other related co-chaperones:

• The region between zinc finger motifs (m2 subdomain, residues 158-199) is critical for substrate release but not for initial binding

• Deletion of this m2 subdomain (DJA2-Δm2) creates a mutant that can bind substrates but cannot release them during transfer to Hsc70

• The release mechanism appears coupled to the Hsc70 ATPase cycle, suggesting a coordinated handover process

• This mechanism differs from DNAJA1, indicating functional specialization within the HSP40 family

Experimental approaches to study this mechanism include:

• Construction of domain-specific mutants (particularly DJA2-Δm2)

• In vitro reconstitution of chaperone systems with purified components

• ATPase activity assays to monitor coupling between substrate release and ATP hydrolysis

• Luciferase refolding assays to quantify functional outcomes of domain mutations

How does DNAJA2 contribute to transcription-coupled repair pathways?

Recent research has identified DNAJA2 as a regulator of transcription-coupled repair (TCR) mechanisms:

• DNAJA2-deficient cells (DJ2−/−) show increased sensitivity to UV irradiation, similar to CSB-knockout cells

• This sensitivity can be reversed by reintroducing wild-type DNAJA2, confirming its role in the DNA damage response

• The J domain of DNAJA2 appears important for this function, as J domain-deleted DNAJA2 cannot fully rescue the phenotype

Methodological considerations when studying DNAJA2 in DNA repair:

• Generate DNAJA2 knockout cell lines using CRISPR/Cas9

• Conduct UV sensitivity assays with varying doses to assess cell viability

• Use domain-specific mutants (particularly J domain deletion mutants)

• Monitor repair of specific DNA lesions (cyclobutane pyrimidine dimers, 6-4 photoproducts)

• Compare with established DNA repair-deficient cells (e.g., CSB−/−) as benchmarks

What are the most common issues when using DNAJA2 antibodies in Western blotting and how can they be resolved?

Common challenges in DNAJA2 Western blotting and their solutions:

Optimization recommendations:

• Use positive control lysates (A431, A375, human brain, or mouse kidney tissue)

• Include both reducing and non-reducing conditions if dimerization is suspected

• Consider membrane type (PVDF vs. nitrocellulose) based on antibody recommendations

• Optimize blocking conditions (BSA vs. milk) to reduce background

How can I optimize immunoprecipitation protocols for DNAJA2 studies?

Successful immunoprecipitation of DNAJA2 requires careful optimization:

• Antibody selection:

  • Use antibodies specifically validated for IP applications

  • Consider using 0.5-4.0 μg antibody per 1-3 mg of total protein lysate

  • Validate specificity in your experimental system

• Lysis conditions:

  • Use non-denaturing buffers to preserve native structure and interactions

  • Include appropriate protease inhibitors to prevent degradation

  • Consider mild detergents (0.5% NP-40 or Triton X-100) to maintain interactions

• Experimental design:

  • Include appropriate negative controls (IgG, irrelevant antibody)

  • Use A375 cells as positive control system for IP protocols

  • For co-IP studies, consider crosslinking to stabilize transient interactions

• Detection strategies:

  • For interactome studies, consider mass spectrometry analysis

  • For known interaction partners, use well-validated antibodies for Western blot detection

  • For viral interaction studies, include both viral and host protein detection systems

How does DNAJA2 contribute to proteasomal degradation buffering and what methods best characterize this function?

Recent research has revealed DNAJA2's role in buffering proteasomal degradation of certain proteins:

• DNAJA2 interacts with specific client proteins, such as TPMT A80P mutant protein, more strongly than with wild-type proteins

• This interaction appears to prevent robust degradation of mutant proteins

• DNAJA2 exhibits specificity in its client protection function, acting on some proteins but not others

Methodological approaches to study this function:

• BioID or TurboID proximity labeling to identify DNAJA2 client proteins

• Reverse BioID approach using DNAJA2-TurboID fusion proteins

• Proteasome inhibitors (e.g., MG132) to confirm degradation mechanisms

• Comparison between wild-type and mutant client proteins

• Pulse-chase experiments to measure protein half-life with and without DNAJA2

What are the latest experimental approaches for studying DNAJA2 interaction networks?

Cutting-edge methodologies for mapping DNAJA2 interaction networks include:

• Proximity-dependent labeling methods:

  • BioID or TurboID fusion constructs allow identification of transient interactions

  • APEX2 labeling for spatial resolution of interactions

  • Split-BioID for detecting specific interaction contexts

• Advanced proteomics approaches:

  • Quantitative interaction proteomics (SILAC, TMT labeling)

  • Crosslinking mass spectrometry (XL-MS) to map interaction domains

  • Thermal proximity coaggregation (TPCA) to detect interactions in living cells

• Live-cell imaging techniques:

  • FRET-based sensors for real-time interaction monitoring

  • Optogenetic tools to manipulate DNAJA2 function with spatial and temporal control

  • Super-resolution microscopy to visualize co-chaperone complexes

• Functional genomic screens:

  • CRISPR screens to identify genetic interactions with DNAJA2

  • RNA-seq after DNAJA2 manipulation to identify regulatory networks

  • Synthetic lethality screens to identify context-dependent functions

These advanced approaches provide higher resolution understanding of DNAJA2's dynamic interactions and context-specific functions in different cellular pathways.

How should I optimize immunofluorescence protocols for DNAJA2 localization studies?

For successful immunofluorescence detection of DNAJA2:

• Fixation and permeabilization:

  • Test both paraformaldehyde (4%) and methanol fixation

  • Optimize permeabilization with Triton X-100 (0.1-0.5%) or saponin

  • Consider antigen retrieval for specific tissues

• Antibody conditions:

  • Use dilutions in the 1:50-1:500 range for most antibodies

  • Extend primary antibody incubation (overnight at 4°C)

  • Include appropriate controls (DNAJA2 knockout cells)

• Co-localization studies:

  • For viral studies, include dsRNA markers for replication complexes

  • Use organelle markers to confirm subcellular localization

  • Consider stress treatments to observe dynamic relocalization

• Advanced imaging:

  • Use confocal microscopy for precise localization

  • Consider super-resolution techniques for detailed co-localization

  • For live-cell studies, validate GFP-tagged DNAJA2 constructs against antibody staining

MCF-7 cells have been validated as a positive control system for DNAJA2 immunofluorescence protocols .

What considerations are important when designing experiments to differentiate between DNAJA1 and DNAJA2 functions?

Despite sharing the HSP40 family classification, DNAJA1 and DNAJA2 have distinct functions requiring careful experimental design:

• Sequence and structural considerations:

  • DNAJA1 and DNAJA2 show low sequence similarity in certain regions

  • They can interact with each other, complicating functional studies

  • Both proteins interact with JEV proteins but may have different roles

• Experimental approaches for functional differentiation:

  • Individual and combined knockdown/knockout

  • Domain-swapping experiments to identify function-specific regions

  • Client-specific binding assays to map preferential interactions

  • Structural studies to identify unique interaction surfaces

• Technical considerations:

  • Validate antibody specificity against both proteins

  • Use tagged versions with different epitopes for co-expression studies

  • Consider endogenous expression levels when interpreting overexpression studies

  • Design siRNAs and shRNAs with confirmed specificity

• Interaction studies:

  • Map interaction networks for both proteins independently

  • Identify unique and shared binding partners

  • Consider competition assays for shared substrates or partners